Company news
Esperion Therapeutics, Inc. news in 2019
Esperion Therapeutics, Inc.'s news releases, calls and decks from 2019, newest first.
Esperion Announces Pooled Analyses from Phase 3 LDL-C Lowering Clinical Development Program of Bempedoic Acid Presented at the American Heart Association 2019 Scientific Sessions
November 16, 2019
Esperion Announces Publication in the Journal of the American Medical Association of Bempedoic Acid Phase 3 Study 2 Results
November 11, 2019
Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Third Quarter Financial Results
November 5, 2019
Esperion Announces Pooled Analyses from Phase 3 LDL-C Lowering Development Program of Bempedoic Acid to be Presented at the American Heart Association 2019 Scientific Sessions
November 3, 2019
Esperion to Report Third Quarter 2019 Financial Results November 6, 2019
October 28, 2019
Esperion Announces Publication in The Journal of the American Heart Association of Bempedoic Acid Study 3 Results
March 31, 2019